| Literature DB >> 29939164 |
Hui-Ching Hsu1, Ming-Feng Liao2, Jung-Lung Hsu2, Yun-Lin Lee2, Long-Sun Ro3.
Abstract
Genetic testing is the most reliable test for hereditary transthyretin related amyloidosis and should be performed in most cases of transthyretin amyloidosis (ATTR). ATTR is a rare but fatal disease with heterogeneous phenotypes; therefore, the diagnosis is sometimes delayed. With increasing attention and broader recognition on early manifestations of ATTR as well as emerging treatments, appropriate diagnostic studies, including the transthyretin (TTR) genetic test, to confirm the types and variants of ATTR are therefore fundamental to improve the prognosis. Genetic analyses with polymerase chain reaction (PCR) methods confirm the presence of TTR point mutations much more quickly and safer than conventional methods such as southern blot. Herein, we demonstrate genetic confirmation of the ATTR Ala97Ser mutation, the most common endemic mutation in Taiwan. The protocol comprises four main steps: collecting whole blood specimen, DNA extraction, genetic analysis of all four TTR exons with PCR, and DNA sequencing.Entities:
Mesh:
Year: 2018 PMID: 29939164 PMCID: PMC6101697 DOI: 10.3791/57743
Source DB: PubMed Journal: J Vis Exp ISSN: 1940-087X Impact factor: 1.355